International Journal of Hepatobiliary and Pancreatic Diseases - IJHPD - Review Articles, Original Articles, Short Communication, Case Series, Case Reports, Letter to Editors
 
  Table of Contents    
Editorial
 
Demethylase JMJD6 as a regulator of innate immunity in HCV-associated liver injury
Natalia A. Osna
Research Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Article ID: 100067IJHPDNO2017
doi:10.5348/ijhpd-2017-67-ED-3

Address correspondence to:
Natalia Osna
MD, PhD, Internal Medicine, UNMC, Veterans Affairs Nebraska-Western Iowa Health Care System
4101 Woolworth Ave, Omaha, NE 68105
USA

Access full text article on other devices

  Access PDF of article on other devices

[HTML Abstract]   [PDF Full Text] [Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar]

How to cite this article
Osna NA. Demethylase JMJD6 as a regulator of innate immunity in HCV-associated liver injury. Int J Hepatobiliary Pancreat Dis 2017;7:15–17.`


Hepatitis C virus (HCV) infection causes the dysfunction of innate immunity in hepatocytes, the primary sites of viral replication. Anti-viral protection of hepatocytes requires the induction of interferon alpha (IFNa) signaling that activates interferon–stimulated genes (ISGs) to control viral replication and spread. The IFNa signaling is initiated by endogenous IFNa released by non-parenchymal liver cells (macrophages, dendritic cells) upon sensing the virus. Binding of IFNa to surface receptors on hepatocytes activates the JAK-STAT pathway. To attach to DNA and induce protective ISGs, STAT1 requires protein methyl transferase 1 (PRMT1)-mediated arginine methylation [1].

While protein expression level is regulated by histone methylation/acetylation, multiple methyltransferases induce the methylation of proteins on various residues (arginine, lysine, etc). In the liver, activities of many methyltransferases are regulated by the methionine metabolic pathway, namely, by the changes in the ratio between the methyl donor, S-adenosyl methionine (SAM) and its toxic metabolite, S-adenosylhomocysteine (SAH). Alcohol and HCV decreases SAM: SAH ratio [2][3][4], suggesting that SAM-dependent PRMT1 and subsequent STAT1 methylation in hepatocytes may be altered due to HCV- and alcohol-induced SAM insufficiency. Indeed, in infected hepatocytes, methylation of STAT1 on Arg-31 is impaired by HCV [5] [6] . Alcohol metabolites further decrease STAT1 methylation, thereby enhancing PIAS1-STAT1 interactions to prevent STAT1 binding to DNA [7]. Although suppression of STAT1 methylation was mainly attributed to PRMT1 dysfunction, we cannot exclude that HCV-induced demethylation of STAT1 also regulates IFNa signaling. In fact, it has been shown recently that the methylation of another innate immunity regulator, TNF receptor-associated factor 6 (TRAF6), is partially controlled by demethylase Jumonji domain-containing protein 6 (JMJD6) [8]. The JMJD6 is a non-heme Fe(II) 2-oxoglutarate (2OG)-dependent oxygenase with bifunctional enzymatic activities, arginine demethylase and lysyl hydroxylase [9][10]. Importantly, STAT1 has never been characterized as a JMJD6 target, and the role of this enzyme in STAT1 methylation in hepatocytes has never been investigated in viral hepatitis.

In our laboratory, we studied whether arginine methylation of STAT1 is modulated by JMJD6 and whether there is a functional link between HCV replication and JMJD6 levels in IFNa-induced anti-viral protection via the JAK-STAT1 pathway in hepatocytes. The modulation of JMJD6 levels by viruses has been already demonstrated in literature [11][12], but nothing is known about the role of JMJD6 in HCV-infection. In our preliminary (unpublished) experiments, we found that in Huh 7.5 (hepatoma) cells, JMJD6 overexpression reduced STAT1 methylation on arginine residue, while JMJD6 silencing increased STAT1 methylation. We also found that JMJD6 suppression enhanced activation ISGs and suppressed HCV RNA; however, there was a negative impact of JMJD6 overexpression on innate immunity (unpublished data). Previously, we indeed observed that impaired STAT1 methylation on both arginine and lysine residues of STAT1 contributed to the suppressed activation of ISGs by IFNa [7]. Surprisingly, JMJD6 provided no effect on lysine STAT1 methylation. The explanation of this discrepancy in JMJD6-induced regulation of arginine and lysine protein methylation is provided by another study demonstrating that JMJD3, but not JMJD6 was responsible for the lysine histone demethylation [13]. The results of our studies suggest that JMJD6 is one of the factors, which regulate HCV infectivity levels in hepatocytes by suppressing ISG activation via the JAK-STAT1, the most important pathways for anti-viral innate immunity protection.

Thus, demethylase JMJD6 definitely plays an important role in the regulation of anti-HCV innate immunity. More studies are necessary to characterize JMJD6 contribution to HCV-infection pathogenesis and to identify other mechanisms by which JMJD6 may control the disease severity and outcomes. The role of this enzyme in the modulation of anti-viral protection makes JMJD6 an attractive target for the therapeutic interventions in viral hepatitis.



Keywords: Hepatitis C virus (HCV), Hepatocytes, Interferon–stimulated genes (ISGs), Jumonji domain-containing protein 6 (JMJD6)


REFERENCES
  1. Mowen KA, Tang J, Zhu W, et al. Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 2001 Mar 9;104(5):731–41.   [CrossRef]   [Pubmed]    Back to citation no. 1
  2. Kharbanda KK. Alcoholic liver disease and methionine metabolism. Seminars in Liver Disease 29(2):155–65.   [CrossRef]    Back to citation no. 2
  3. Osna N, McVicker B, Poluektova L, Ganesan M, Kharbanda K. Mode of oral ethanol feeding affects liver oxidative stress levels and methylation status: Study on NS5A-transgenic Mice. International Journal of Biochemistry Research & Review 2014;4(4):344–57.   [CrossRef]    Back to citation no. 3
  4. Osna NA, Bardag-Gorce F, White RL, Weinman SA, Donohue TM Jr, Kharbanda KK. Ethanol and hepatitis C virus suppress peptide-MHC class I presentation in hepatocytes by altering proteasome function. Alcohol Clin Exp Res 2012 Dec;36(12):2028–35.   [CrossRef]    Back to citation no. 4
  5. Duong FH, Filipowicz M, Tripodi M, La Monica N, Heim MH. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 2004 Jan;126(1):263–77.   [CrossRef]   [Pubmed]    Back to citation no. 5
  6. Duong FHT, Christen V, Berke JM, Penna SH, Moradpour D, Heim MH. Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1. J Virol 2005;79(24):15342–50.   [CrossRef]    Back to citation no. 6
  7. Ganesan M, Zhang J, Bronich T, et al. Acetaldehyde accelerates HCV-induced impairment of innate immunity by suppressing methylation reactions in liver cells. American Journal of Physiology - Gastrointestinal and Liver Physiology Published 2015;309(7):G566–77.   [CrossRef]    Back to citation no. 7
  8. Tikhanovich I, Kuravi S, Artigues A, et al. Dynamic arginine methylation of tumor necrosis factor (TNF) receptor-associated factor 6 regulates toll-like receptor signaling. J Biol Chem 2015 Sep 4;290(36):22236–49.   [CrossRef]   [Pubmed]    Back to citation no. 8
  9. Chang B, Chen Y, Zhao Y, Bruick RK. JMJD6 is a histone arginine demethylase. Science 2007 Oct 19;318(5849):444–7.   [CrossRef]   [Pubmed]    Back to citation no. 9
  10. Webby CJ, Wolf A, Gromak N, et al. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science 2009 Jul 3;325(5936):90–3.   [CrossRef]   [Pubmed]    Back to citation no. 10
  11. Lawrence P, Pacheco J, Stenfeldt C, Arzt J, Rai DK, Rieder E. Pathogenesis and micro-anatomic characterization of a cell-adapted mutant foot-and-mouth disease virus in cattle: Impact of the Jumonji C-domain containing protein 6 (JMJD6) and route of inoculation. Virology 2016 May;492:108–17.   [CrossRef]   [Pubmed]    Back to citation no. 11
  12. Chen CF, Feng X, Liao HY, et al. Regulation of T cell proliferation by JMJD6 and PDGF-BB during chronic hepatitis B infection. Sci Rep 2014 Sep 15;4:6359.   [CrossRef]   [Pubmed]    Back to citation no. 12
  13. Salminen A, Kaarniranta K, Hiltunen M, Kauppinen A. Histone demethylase Jumonji D3 (JMJD3/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging process. J Mol Med (Berl) 2014 Oct;92(10):1035–43.   [CrossRef]   [Pubmed]    Back to citation no. 13
[HTML Abstract]   [PDF Full Text]

Author Contributions
Natalia A. Osna – Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Guarantor of submission
The corresponding author is the guarantor of submission.
Source of support
None
Conflict of interest
Authors declare no conflict of interest.
Copyright
© 2017 Natalia A. Osna. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.



  Home line About IJHPD line Aim and Scope line Sections line Open Access line Archives
Apply as Editor line Apply as Reviewer line Submit Reviews - Editors line Submit Reviews - Reviewers
Instructions for Authors line Templates to Use line Copyright Form line Author Checklist
Online Submission line Email Submission line Submit Revision line Submit All Forms line Submit Page Proofs
Terms of Service line Privacy policy line Disclaimer line FAQ line Contact: Journal line Contact: Edorium Journals line Site Map
 
  Copyright © 2017. Edorium. All rights reserved.